13. STOCKHOLDERS’ EQUITY (Details) (USD $)	3 Months Ended		9 Months Ended				9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 Preferred Series A	Dec. 31, 2012 Preferred Series A	Sep. 30, 2013 Preferred Series C	Sep. 30, 2013 Common Stock	Sep. 30, 2013 Additional Paid-In Capital	Sep. 30, 2013 Retained Earnings
Beginning Balance, Shares					22,034	22,034	88,888	28,179,096
Beginning Balance, Amount			$ (7,642,145)		$ 22	$ 22	$ 89	$ 27,988	$ 16,645,345	$ (24,315,589)
Convert Preferred C to Common, Shares							(1,743)	610,015
Convert Preferred C to Common, Amount							(2)	610	(608)
Common Stock and Warrants Issued for Cash, Shares								1,346,154
Common Stock and Warrants Issued for Cash, Amount			175,000					1,346	173,654
Common Stock Issued for Cash, Shares								100,000
Common Stock Issued for Cash, Amount			18,000					100	17,900
Common Stock Issued to Satisfy Debt Obligation of Avant Diagnostics, Inc., Shares								500,000
Common Stock Issued to Satisfy Debt Obligation of Avant Diagnostics, Inc., Amount			60,000					500	59,500
Cashless Exercise of Warrant, Shares								184,350
Cashless Exercise of Warrant, Amount								184	(184)
Net (loss)	28,313	(39,476)	134,736	(1,353,171)						134,737
Ending Balance, Shares					22,034	22,034	87,145	30,919,615
Ending Balance, Amount	$ (7,254,406)		$ (7,254,406)		$ 22	$ 22	$ 87	$ 30,728	$ 16,895,607	$ (24,180,852)